Prescription drug · ANDA
Fluorouracil NDC 21922-041
Fluorouracil 50 mg/mL · Solution · Topical · Encube Ethicals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 21922-041-12 | 2192200411221922004112 | 1 BOTTLE in 1 CARTON (21922-041-12) / 10 mL in 1 BOTTLEMarketed from Nov 6, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fluorouracil
- Generic name (nonproprietary)
- fluorouracil
- Active ingredients
- Fluorouracil — 50 mg/mL
- Dosage form
- Solution
- Route
- Topical
- Labeler
- Encube Ethicals, Inc.NDC labeler code 21922
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215612
- Marketing start
- Listing expires
- Other FDA classes
- Nucleic Acid Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 21922-041_f42c30f3-a83e-4721-8aa1-50d56cb13f4eSPL ID f42c30f3-a83e-4721-8aa1-50d56cb13f4eSPL set ID 2c631ce7-ea15-4b51-b5bc-4962e3c315cdRxCUI 310380UNII U3P01618RTUPC 0321922041125
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N421922004112followed by a unit qualifier and the quantityPackage 21922-0041-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: Fluorouracil is recommended for the topical treatment of multiple actinic or solar keratoses. In the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Safety and efficacy in other indications have not been established. The diagnosis should be established prior to treatment, since this method has not been proven effective in other types of basal cell carcinomas. With isolated, easily accessible basal cell carcinomas, surgery is preferred since success with such lesions is almost 100%. The success rate with fluorouracil solution and a …
Excerpt only. Read the full label for complete information.
About NDC 21922-041
- What is NDC 21922-041?
- 21922-041 is the product NDC for Fluorouracil, Fluorouracil 50 mg/mL solution, listed with the FDA by Encube Ethicals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Fluorouracil.
- What is the active ingredient?
- Fluorouracil.
- Who is the labeler?
- Encube Ethicals, Inc., NDC labeler code 21922. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Fluorouracil?
- 40 other product NDCs are listed under this name. See all Fluorouracil NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Fluorouracil products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-972 | 23155-0972-41 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-973 | 23155-0973-41 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-974 | 23155-0974-31 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-975 | 23155-0975-31 |
| Fluorouracilfluorouracil cream, 0.5% | Fluorouracil 5 mg/g | CreamTopical | Dr. Reddy's Laboratories Inc. | 75907-169 | 75907-0169-11 |
| Fluorouracil | Fluorouracil 2 g/40g | CreamTopical | Encube Ethicals, Inc. | 21922-049 | 21922-0049-17 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-154 | 71288-0154-76 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | BluePoint Laboratories | 68001-628 | 68001-0628-32 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | BluePoint Laboratories | 68001-627 | 68001-0627-27 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-170 | 71288-0170-75 |